تحميل...
Voxelotor: alteration of sickle cell disease pathophysiology by a first-in-class polymerization inhibitor
Sickle cell disease, despite its recognition as a severely debilitating genetic condition affecting hundreds of thousands of neonates throughout the world each year, was not a target of pharmaceutical research focus for most of its 100-year existence in the medical consciousness. This has changed in...
محفوظ في:
| الحاوية / القاعدة: | Ther Adv Hematol |
|---|---|
| المؤلفون الرئيسيون: | , , , |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
SAGE Publications
2021
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7983433/ https://ncbi.nlm.nih.gov/pubmed/33796238 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/20406207211001136 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|